October 22, 2002 -- IMPAX Laboratories, Inc. (Nasdaq NM: IPXL) today announced
that the Company will release its financial results for the third quarter of
2002 on Monday, October 28, 2002.
Barry R. Edwards, co-chief executive officer, and Cornel C. Spiegler, chief
financial officer, will host an investment-community conference call beginning
at 2:00 p.m. Eastern Time (11 a.m. Pacific Time) to discuss these results and
to answer questions.
To participate in the live call by telephone, please dial (888) 803-7396 from
the U.S., or for international callers, please dial (706) 634-1052.
Those interested in listening to the conference call live via the Internet
may do so by visiting the Company's Web site at www.impaxlabs.com. To listen
to the live call, please go to the Website 15 minutes prior to its start to
register, download, and install the necessary audio software.
A replay will be available on the Company Web site for 14 days. A telephone
replay will be available for 48 hours by dialing (800) 642-1687 from the U.S.,
or (706) 645-9291 for international callers, and entering reservation 6297437.
IMPAX Laboratories, Inc. is a technology based specialty pharmaceutical company
applying its formulation expertise and drug delivery technology to the development
of controlled-release and niche generics in addition to the development of branded
products. IMPAX markets its generic products through its Global Pharmaceuticals
division and intends to market its branded products through the IMPAX Pharmaceuticals
division. IMPAX Laboratories is headquartered in Hayward, California, and has
a full range of capabilities in its Hayward and Philadelphia facilities. For
more information, please visit the Company's Web site at: www.impaxlabs.com.